1h Free Analyst Time
The AI in clinical trials market is forecasted to grow by USD 1.26 billion during 2024-2029, accelerating at a CAGR of 14.5% during the forecast period. The report on the AI in clinical trials market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by pressing need to mitigate escalating clinical trial costs and complexity, proliferation of big data and advanced analytics capabilities, and surging investment and strategic collaborations fueling innovation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The AI in clinical trials market is segmented as below:
By Component
- Solutions
- Services
By Deployment
- Cloud-based
- On-premises
By Application
- Patient recruitment
- Data management and quality control
- Trail design and optimization
- Adverse event prediction and detection
- Others
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the AI in clinical trials market covers the following areas:
- AI In Clinical Trials Market sizing
- AI In Clinical Trials Market forecast
- AI In Clinical Trials Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 The Publisher's Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Five Forces Analysis
7 Market Segmentation by Component
8 Market Segmentation by Deployment
9 Market Segmentation by Application
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global ai in clinical trials market: AiCure, ConcertAI Inc., Deep Genomics Inc., Exscientia PLC, Insilico Medicine, International Business Machines Corp., IQVIA Holdings Inc., Koneksa Health Inc., Medidata, Microsoft Corp., NVIDIA Corp., PathAI Inc., PHARMASEAL, Saama Technologies Inc., Symphony Innovation LLC, Tempus Labs Inc., Unlearn.ai Inc, and Verily.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is ascendancy of generative ai in drug discovery and clinical trial design."
According to the report, one of the major drivers for this market is the pressing need to mitigate escalating clinical trial costs and complexity.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AiCure
- ConcertAI Inc.
- Deep Genomics Inc.
- Exscientia PLC
- Insilico Medicine
- International Business Machines Corp.
- IQVIA Holdings Inc.
- Koneksa Health Inc.
- Medidata
- Microsoft Corp.
- NVIDIA Corp.
- PathAI Inc.
- PHARMASEAL
- Saama Technologies Inc.
- Symphony Innovation LLC
- Tempus Labs Inc.
- Unlearn.ai Inc
- Verily
